Uzbekistan and South Korea held discussions on the next steps for implementing the 'Intelligent Biocluster' investment project, which is aimed at developing biotechnology and pharmaceutical production.
Tashkent, Uzbekistan (UzDaily.uz)
The project discussion took place between Abdullah Azizov, Director of the Agency for the Development of Medical and Pharmaceutical Industry, and Kim Bok-hwan, President of the Korea Infrastructure and Urban Development Corporation (KIND).
During the visit, a delegation from South Korea inspected a 60-hectare site allocated for this cluster. The participants reviewed the concept of the future complex and discussed practical aspects related to site preparation, functional zoning, placement of production facilities, and construction of necessary infrastructure.
As part of the visit program, there was also a tour of the GrandPharm enterprise, one of Uzbekistan's largest pharmaceutical companies. Company representatives presented the delegation with the main areas of its activity, including pharmaceutical logistics, product promotion, franchising, marketing, and educational programs.
The dialogues focused on coordinating the next stages of the project and expanding cooperation between the two countries in the fields of biotechnology and pharmaceuticals. The 'Intelligent Biocluster' is envisioned as a platform for creating modern production capacities and attracting investments into relevant sectors of the Uzbek economy.
